Gilead Sciences, Inc. (GILD)
Jul 17 4:00pm Add GILD to Watchlist Sign Up
Buy & Hold Grade
Peer Grade Industry Rank
GILD News Stream
All News Types
Acquisition Barron's Biotechnology Buyback Commentary Corp. News Cramer Debt Offering Dividend Downgrade Earnings Guidance Down Healthcare Hedge Fund M&A Mgmt Change New Coverage (Bullish) New Coverage (Neutral) Options Product News PT Lowered PT Raised PT Set (Bullish) Rating Reiterated (Bullish) Rating Reiterated (Neutral) Resumes Coverage (Bullish) Resumes Coverage (Neutral) Rumor Upgrade
Loading, please wait...
View All GILD News
Gilead Sciences, Inc. (GILD) Company Bio
Gilead Sciences is a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs. The Company's primary areas of focus include HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions.
GILD Price/Volume Stats
Page generated in 0.4833 seconds.